Back to Howard Marks
Howard Marks → INDV via OAKTREE CAPITAL MANAGEMENT LP
Howard Marks INDV Position History
Indivior Pharmaceuticals, Inc.
Quarters held
10
Latest value
$251.4M
Q2 2026
Peak value
$255.1M
First seen
Q1 2024
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $251.4M | 6.13M | — | — |
| Q1 2026 | $212.9M | 6.98M | — | — |
| Q4 2025 | $255.1M | 7.11M | — | — |
| Q3 2025 | $10.7M | 257.79M | — | — |
| Q2 2025 | $162.3M | 11.01M | — | — |
| Q1 2025 | $103.5M | 11.01M | — | — |
| Q4 2024 | $112M | 8.73M | — | — |
| Q3 2024 | $94.1M | 9.52M | — | — |
| Q2 2024 | $70.4M | 4.49M | — | — |
| Q1 2024 | $71.7M | 3.35M | — | — |